Updates in bladder, kidney and testes cancer from ASCO 2022

Latest updates in treatment for the field of HER2-positive breast cancer

War in Ukraine: Global cancer aid to support refugees

War in Ukraine: The International Brain Tumour Alliance's response to aiding refugees during the crisis

CAR-T cell therapy targeting BCMA is highly effective for patients with relapsed/refractory multiple myeloma

Ponatinib and blinatumomab shows complete molecular response for patients with Philadelphia chromosome-positive ALL

Subcutaneous isatuximab administration in combination with pomalidomide-dexamethasone in RRMM can improve convenience and relieve burden for patients

Time-limited venetoclax-obinutuzumab +/- ibrutnib surpasses chemoimmunotherapy in frontline chronic lymphocytic leukaemia

Targeted therapy combinations with venetoclax superior to chemoimmunotherapy in frontline CLL

A novel CAR-T cell therapy targeting BCMA is highly effective for patients with relapsed/refractory multiple myeloma

ASCO 2022: Head and neck cancer highlights

Biomarker analysis of the NeoALTTO trial provides oncofertility insight for younger breast cancer patients